Defining immunological dysfunction in sepsis: A requisite tool for precision medicine

Journal of Infection

Volumn 72, Issue 5, 2016, Pages 525-536

  Bermejo Martin, Jesús F ^a   Andaluz Ojeda, David ^a   Almansa, Raquel ^a   Gandía, Francisco ^a   Gómez Herreras, Jose Ignacio ^a   Gomez Sanchez, Esther ^a   Heredia Rodríguez, María ^a   Eiros, Jose Maria ^a   Kelvin, David J ^b,c,d   Tamayo, Eduardo ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF SASSARI   (Italy)

^d SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Antigen presentation; Complement; Dysfunction; Immunoglobulins; Immunological; Neutrophils; PD 1; Sepsis; T B lymphocytes; Tregs

Indexed keywords

ALPHA INTERFERON; COMPLEMENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTERLEUKIN 15; INTERLEUKIN 6; OLIGODEOXYNUCLEOTIDE; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 7; SMALL INTERFERING RNA; THYMOSIN ALPHA1; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; B LYMPHOCYTE; BACTERICIDAL ACTIVITY; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; CYTOKINE STORM; EXTRACELLULAR TRAP; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; INNATE IMMUNITY; MEDLINE; META ANALYSIS (TOPIC); NATURAL KILLER CELL; NEUTROPHIL COUNT; PERSONALIZED MEDICINE; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVIEW; SEPSIS; SYSTEMATIC REVIEW; T LYMPHOCYTE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; SEPSIS;

EID: 84957676640     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.01.010     Document Type: Review

References (102)

1. Fleischmann Carolin, Scherag André, Adhikari Neill Kj, Hartog Christiane S., Tsaganos Thomas, Schlattmann Peter, et al. Assessment of global incidence and mortality of hospital-treated sepsis - current estimates and limitations. Am J Respir Crit Care Med 2015, 10.1164/rccm.201504-0781OC.
2. Vincent Jean-Louis, Opal Steven M., Marshall John C., Tracey Kevin J. Sepsis definitions: time for change. Lancet 2013, 381(9868):774-775. 10.1016/S0140-6736(12)61815-7.
3. Hotchkiss Richard S., Monneret Guillaume, Payen Didier Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013, 13(3):260-268. 10.1016/S1473-3099(13)70001-X.
4. Henriksen Daniel Pilsgaard, Pottegård Anton, Laursen Christian B., Jensen Thøger Gorm, Hallas Jesper, Pedersen Court, et al. Risk factors for hospitalization due to community-acquired sepsis - a population-based case-control study. PLoS One 2015, 10(4):e0124838. 10.1371/journal.pone.0124838.
5. Hutchins Noelle A., Unsinger Jacqueline, Hotchkiss Richard S., Ayala Alfred The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med 2014, 20(4):224-233. 10.1016/j.molmed.2014.01.002.
6. Cohen Jonathan, Vincent Jean-Louis, Adhikari Neill KJ., Machado Flavia R., Angus Derek C., Calandra Thierry, et al. Sepsis: a roadmap for future research. Lancet Infect Dis 2015, 15(5):581-614. 10.1016/S1473-3099(15)70112-X.
7. Lopez Juanita, Harris Sam, Roda Desam, Yap Timothy A. Precision medicine for molecularly targeted agents and immunotherapies in early-phase clinical trials. Transl Oncogenomics 2015, 7(Suppl. 1):1-11. 10.4137/TOG.S30533.
8. Fan Xia, Liu Zheng, Jin He, Yan Jun, Liang Hua-ping Alterations of dendritic cells in sepsis: featured role in immunoparalysis. Biomed Res Int 2015, 2015:903720. 10.1155/2015/903720.
9. Poehlmann Holger, Schefold Joerg C., Zuckermann-Becker Heidrun, Volk Hans-Dieter, Meisel Christian Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care 2009, 13(4):R119. 10.1186/cc7969.
10. Bhardwaj Nidhi, Mathur Purva, Kumar Subodh, Gupta Amit, Gupta Deepak, John Nibu V., et al. Depressed monocytic activity may be a predictor for sepsis. J Lab Physicians 2015, 7(1):26-31. 10.4103/0974-2727.154785.
11. Shalova Irina N., Lim Jyue Yuan, Chittezhath Manesh, Zinkernagel Annelies S., Beasley Federico, Hernández-Jiménez Enrique, et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1α. Immunity 2015, 42(3):484-498. 10.1016/j.immuni.2015.02.001.
12. Kjaergaard A.G., Nielsen J.S., Tønnesen E., Krog J. Expression of NK cell and monocyte receptors in critically ill patients-potential biomarkers of sepsis. Scand J Immunol 2015, 81(4):249-258. 10.1111/sji.12272.
13. Boomer Jonathan S., To Kathleen, Chang Kathy C., Takasu Osamu, Osborne Dale F., Walton Andrew H., et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306(23):2594-2605. 10.1001/jama.2011.1829.
14. Monneret Guillaume, Lepape Alain, Voirin Nicolas, Bohé Julien, Venet Fabienne, Debard Anne-Lise, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006, 32(8):1175-1183. 10.1007/s00134-006-0204-8.
15. Cazalis Marie-Angélique, Friggeri Arnaud, Cavé Laura, Demaret Julie, Barbalat Véronique, Cerrato Elisabeth, et al. Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock. Crit Care 2013, 17(6):R287. 10.1186/cc13150.
16. Landelle Caroline, Lepape Alain, Voirin Nicolas, Tognet Eve, Venet Fabienne, Bohé Julien, et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 2010, 36(11):1859-1866. 10.1007/s00134-010-1962-x.
17. Venet Fabienne, Davin Fanny, Guignant Caroline, Larue Audrey, Cazalis Marie-Angélique, Darbon Romain, et al. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 2010, 34(4):358-363. 10.1097/SHK.0b013e3181dc0977.
18. de Pablo Raul, Monserrat Jorge, Prieto Alfredo, Alvarez-Mon Melchor Role of circulating lymphocytes in patients with sepsis. Biomed Res Int 2014, 2014:671087. 10.1155/2014/671087.
19. Hotchkiss R.S., Tinsley K.W., Swanson P.E., Schmieg R.E., Hui J.J., Chang K.C., et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001, 166(11):6952-6963.
20. Nogales L., Avila A., Bobillo F., Iglesias V., Villanueva N.F., Cicuendez R., et al. Lymphocyte subsets count in blood as tool for diagnosis of severe sepsis. Intensive Care Med 2014, 40. S88-S88.
21. Zhang Yan, Li Jinbao, Lou Jingsheng, Zhou Ying, Bo Lulong, Zhu Jiali, et al. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care 2011, 15(1):R70. 10.1186/cc10059.
22. Monserrat Jorge, de Pablo Raul, Reyes Eduardo, Díaz David, Barcenilla Hugo, Zapata Manuel R., et al. Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care 2009, 13(1):R26. 10.1186/cc7731.
23. Drewry Anne M., Samra Navdeep, Skrupky Lee P., Fuller Brian M., Compton Stephanie M., Hotchkiss Richard S. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 2014, 42(5):383-391. 10.1097/SHK.0000000000000234.
24. Almansa Raquel, Heredia-Rodríguez María, Gomez-Sanchez Esther, Andaluz-Ojeda David, Iglesias Verónica, Rico Lucia, et al. Transcriptomic correlates of organ failure extent in sepsis. J Infect 2015, 70(5):445-456. 10.1016/j.jinf.2014.12.010.
25. Wong Hector R. Genome-wide expression profiling in pediatric septic shock. Pediatr Res 2013, 73(4 Pt 2):564-569. 10.1038/pr.2013.11.
26. Shanley Thomas P., Cvijanovich Natalie, Lin Richard, Allen Geoffrey L., Thomas Neal J., Doctor Allan, et al. Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007, 13(9-10):495-508. 10.2119/2007-00065.Shanley.
27. Parnell Grant P., Tang Benjamin M., Nalos Marek, Armstrong Nicola J., Huang Stephen J., Booth David R., et al. Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions. Shock 2013, 40(3):166-174. 10.1097/SHK.0b013e31829ee604.
28. Cazalis Marie-Angélique, Lepape Alain, Venet Fabienne, Frager Florence, Mougin Bruno, Vallin Hélène, et al. Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach. Intensive Care Med Exp 2014, 2(1):20. 10.1186/s40635-014-0020-3.
29. Tsalik Ephraim L., Langley Raymond J., Dinwiddie Darrell L., Miller Neil A., Yoo Byunggil, van Velkinburgh Jennifer C., et al. An integrated transcriptome and expressed variant analysis of sepsis survival and death. Genome Med 2014, 6(11):111. 10.1186/s13073-014-0111-5.
30. Inoue Shigeaki, Suzuki-Utsunomiya Kyoko, Okada Yoshinori, Taira Takayuki, Iida Yumi, Miura Naoya, et al. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med 2013, 41(3):810-819. 10.1097/CCM.0b013e318274645f.
31. Andreu-Ballester Juan C., Cuellar Carmen, Garcia-Ballesteros Carlos, Pérez-Griera Jaime, Amigó Victoria, Peiró-Gómez Ana, et al. Deficit of interleukin 7 in septic patients. Int Immunopharmacol 2014, 23(1):73-76. 10.1016/j.intimp.2014.08.015.
32. Forel Jean-Marie, Chiche Laurent, Thomas Guillemette, Mancini Julien, Farnarier Catherine, Cognet Céline, et al. Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS One 2012, 7(12):e50446. 10.1371/journal.pone.0050446.
33. Souza-Fonseca-Guimaraes Fernando, Parlato Marianna, Philippart François, Misset Benoît, Cavaillon Jean-Marc, Adib-Conquy Minou, et al. Toll-like receptors expression and interferon-γ production by NK cells in human sepsis. Crit Care 2012, 16(5):R206. 10.1186/cc11838.
34. Monneret Guillaume, Venet Fabienne Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy. Cytometry B Clin Cytom 2015, 10.1002/cyto.b.21270.
35. de Pablo Raúl, Monserrat Jorge, Torrijos Carolina, Martín Mercedes, Prieto Alfredo, Alvarez-Mon Melchor The predictive role of early activation of natural killer cells in septic shock. Crit Care 2012, 16(2):413. 10.1186/cc11204.
36. Andaluz-Ojeda David, Iglesias Verónica, Bobillo Felipe, Almansa Raquel, Rico Lucía, Gandía Francisco, et al. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 2011, 15(5):R243. 10.1186/cc10501.
37. Monneret Guillaume, Debard Anne-Lise, Venet Fabienne, Bohe Julien, Hequet Olivier, Bienvenu Jacques, et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003, 31(7):2068-2071. 10.1097/01.CCM.0000069345.78884.0F.
38. Cao Chao, Ma Tao, Chai Yan-Fen, Shou Song-Tao The role of regulatory T cells in immune dysfunction during sepsis. World J Emerg Med 2015, 6(1):5-9. 10.5847/wjem.j.1920-8642.2015.01.001.
39. Huang Huihuang, Xu Ruonan, Lin Fang, Bao Chunmei, Wang Siyu, Ji Chengcheng, et al. High circulating CD39(+) regulatory T cells predict poor survival for sepsis patients. Int J Infect Dis 2015, 30:57-63. 10.1016/j.ijid.2014.11.006.
40. Hein François, Massin Frédéric, Cravoisy-Popovic Aurélie, Barraud Damien, Levy Bruno, Bollaert Pierre-Edouard, et al. The relationship between CD4+CD25+CD127-regulatory T cells and inflammatory response and outcome during shock states. Crit Care 2010, 14(1):R19. 10.1186/cc8876.
41. Guignant Caroline, Lepape Alain, Huang Xin, Kherouf Hakim, Denis Laure, Poitevin Françoise, et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care 2011, 15(2):R99. 10.1186/cc10112.
42. Venet Fabienne, Gebeile Rémi, Bancel Julien, Guignant Caroline, Poitevin-Later Françoise, Malcus Christophe, et al. Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients. Int Immunopharmacol 2011, 11(12):2086-2090. 10.1016/j.intimp.2011.08.024.
43. Tamayo Eduardo, Fernández Ana, Almansa Raquel, Carrasco Elena, Goncalves Lisbeth, Heredia María, et al. Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock. J Crit Care 2012, 27(6):616-622. 10.1016/j.jcrc.2012.08.004.
44. Taccone Fabio Silvio, Stordeur Patrick, De Backer Daniel, Creteur Jacques, Vincent Jean-Louis Gamma-globulin levels in patients with community-acquired septic shock. Shock 2009, 32(4):379-385. 10.1097/SHK.0b013e3181a2c0b2.
45. Průcha M., Zazula R., Herold I., Dostál M., Hyánek T., Bellingan G. Presence of hypogammaglobulinemia - a risk factor of mortality in patients with severe sepsis, septic shock, and SIRS. Prague Med Rep 2013, 114(4):246-257.
46. Almansa Raquel, Tamayo Eduardo, Heredia María, Gutierrez Sandra, Ruiz Patricia, Alvarez Elisa, et al. Transcriptomic evidence of impaired immunoglobulin G production in fatal septic shock. J Crit Care 2014, 29(2):307-309. 10.1016/j.jcrc.2013.11.020.
47. Tamayo Eduardo, Almansa Raquel, Carrasco Elena, Ávila-Alonso Ana, Rodríguez-Fernández Ana, Wain John, et al. Quantification of IgM molecular response by droplet digital PCR as a potential tool for the early diagnosis of sepsis. Crit Care 2014, 18(3):433. 10.1186/cc13910.
48. Shankar-Hari Manu, Culshaw Nicholas, Post Benjamin, Tamayo Eduardo, Andaluz-Ojeda David, Bermejo-Martín Jesús F., et al. Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis. Intensive Care Med 2015, 41(8):1393-1401. 10.1007/s00134-015-3845-7.
49. Bermejo-Martín J.F., Rodriguez-Fernandez A., Herrán-Monge R., Andaluz-Ojeda D., Muriel-Bombín A., Merino P., et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med 2014, 276(4):404-412. 10.1111/joim.12265.
50. Shankar-Hari Manu, Spencer Jo, Sewell William A., Rowan Kathryn M., Singer Mervyn Bench-to-bedside review: immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Crit Care 2012, 16(2):206. 10.1186/cc10597.
51. Bermejo-Martin J.F., Giamarellos-Bourboulis E.J. Endogenous immunoglobulins and sepsis: new perspectives for guiding replacement therapies. Int J Antimicrob Agents 2015 Dec, 46(Suppl. 1):S25-S28.
52. Giamarellos-Bourboulis Evangelos J., Apostolidou Efterpi, Lada Malvina, Perdios Ioannis, Gatselis Nikolaos K., Tsangaris Iraklis, et al. Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit Care 2013, 17(5):R247. 10.1186/cc13073.
53. Stentzel Sebastian, Sundaramoorthy Nandakumar, Michalik Stephan, Nordengrün Maria, Schulz Sarah, Kolata Julia, et al. Specific serum IgG at diagnosis of Staphylococcus aureus bloodstream invasion is correlated with disease progression. J Proteomics 2015, 128:1-7. 10.1016/j.jprot.2015.06.018.
54. Kovach Melissa A., Standiford Theodore J. The function of neutrophils in sepsis. Curr Opin Infect Dis 2012, 25(3):321-327. 10.1097/QCO.0b013e3283528c9b.
55. Alves-Filho José C., Spiller Fernando, Cunha Fernando Q. Neutrophil paralysis in sepsis. Shock 2010, 34(Suppl. 1):15-21. 10.1097/SHK.0b013e3181e7e61b.
56. Bermejo-Martín Jesús F., Tamayo Eduardo, Ruiz Gema, Andaluz-Ojeda David, Herrán-Monge Rubén, Muriel-Bombín Arturo, et al. Circulating neutrophil counts and mortality in septic shock. Crit Care 2014, 18(1):407. 10.1186/cc13728.
57. Brown K.Alun, Treacher David F. Neutrophils as potential therapeutic targets in sepsis. Discov Med 2006, 6(33):118-122.
58. Mare Tracey Anne, Treacher David Floyd, Shankar-Hari Manu, Beale Richard, Lewis Sion Marc, Chambers David John, et al. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit Care 2015, 19:57. 10.1186/s13054-015-0778-z.
59. Demaret Julie, Venet Fabienne, Friggeri Arnaud, Cazalis Marie-Angélique, Plassais Jonathan, Jallades Laurent, et al. Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J Leukoc Biol 2015, 10.1189/jlb.4A0415-168RR.
60. Timofey Kalupov, Michèle Brillard-Bourdet, Sébastien Dadé, Hélène Serrano, Julien Wartelle, Nicolas Guyot, et al. Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases. J Biol Chem 2009, 284(49):34084-34091. 10.1074/jbc.M109.042903.
61. Brown K.A., Brain S.D., Pearson J.D., Edgeworth J.D., Lewis S.M., Treacher D.F. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006, 368(9530):157-169. 10.1016/S0140-6736(06)69005-3.
62. Gabelloni María Laura, Trevani Analía Silvina, Sabatté Juan, Geffner Jorge Mechanisms regulating neutrophil survival and cell death. Semin Immunopathol 2013, 35(4):423-437. 10.1007/s00281-013-0364-x.
63. Fox Elizabeth D., Heffernan Daithi S., Cioffi William G., Reichner Jonathan S. Neutrophils from critically ill septic patients mediate profound loss of endothelial barrier integrity. Crit Care 2013, 17(5):R226. 10.1186/cc13049.
64. Meyer-Hoffert Ulf, Wiedow Oliver Neutrophil serine proteases: mediators of innate immune responses. Curr Opin Hematol 2011, 18(1):19-24. 10.1097/MOH.0b013e32834115d1.
65. van den Berg Carmen W., Tambourgi Denise V., Clark Howard W., Hoong S.Julie, Spiller O.Brad, McGreal Eamon P. Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor. J Immunol 2014, 192(4):1787-1795. 10.4049/jimmunol.1301920.
66. Xu Ruonan, Lin Fang, Bao Chunmei, Huang Huihuang, Ji Chengcheng, Wang Siyu, et al. Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis. Cell Mol Immunol 2015, 10.1038/cmi.2014.136.
67. Miyoshi Seigo, Hamada Hironobu, Ito Ryoji, Katayama Hitoshi, Irifune Kazunori, Suwaki Toshimitsu, et al. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis. Drug Des Devel Ther 2013, 7:305-316. 10.2147/DDDT.S42004.
68. Guérin Estelle, Orabona Marie, Raquil Marie-Astrid, Giraudeau Bruno, Bellier Rémy, Gibot Sébastien, et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration. Crit Care Med 2014, 42(9):2007-2018. 10.1097/CCM.0000000000000344.
69. Tamayo Eduardo, Fernández Ana, Almansa Raquel, Carrasco Elena, Heredia María, Lajo Carmen, et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw 2011, 22(2):82-87. 10.1684/ecn.2011.0281.
70. Andaluz-Ojeda David, Bobillo Felipe, Iglesias Verónica, Almansa Raquel, Rico Lucía, Gandía Francisco, et al. A combined score of pro- and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine 2012, 57(3):332-336. 10.1016/j.cyto.2011.12.002.
71. Chaudhry Hina, Zhou Juhua, Zhong Yin, Ali Mir Mustafa, McGuire Franklin, Nagarkatti Prakash S., et al. Role of cytokines as a double-edged sword in sepsis. In Vivo 2013, 27(6):669-684.
72. Pierrakos Charalampos, Vincent Jean-Louis Sepsis biomarkers: a review. Crit Care 2010, 14(1):R15. 10.1186/cc8872.
73. Tang Benjamin M., Huang Stephen J., McLean Anthony S. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care 2010, 14(6):R237. 10.1186/cc9392.
74. de Pablo Raúl, Monserrat Jorge, Reyes Eduardo, Diaz-Martin David, Rodriguez Zapata Manuel, Carballo Fernando, et al. Mortality in patients with septic shock correlates with anti-inflammatory but not proinflammatory immunomodulatory molecules. J Intensive Care Med 2011, 26(2):125-132. 10.1177/0885066610384465.
75. Bermejo-Martin Jesus F., Martin-Loeches Ignacio, Rello Jordi, Antón Andres, Almansa Raquel, Xu Luoling, et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 2010, 14(5):R167. 10.1186/cc9259.
76. Ward Peter A., Gao Hongwei Sepsis, complement and the dysregulated inflammatory response. J Cell Mol Med 2009, 13(10):4154-4160. 10.1111/j.1582-4934.2009.00893.x.
77. Lin R.Y., Astiz M.E., Saxon J.C., Saha D.C., Rackow E.C. Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol 1993, 69(2):136-142.
78. Sprung C.L., Schultz D.R., Marcial E., Caralis P.V., Gelbard M.A., Arnold P.I., et al. Complement activation in septic shock patients. Crit Care Med 1986, 14(6):525-528.
79. Stover Cordula M., McDonald John, Byrne Simon, Lambert David G., Thompson Jonathan P. Properdin levels in human sepsis. Front Immunol 2015, 6:24. 10.3389/fimmu.2015.00024.
80. Charchaflieh Jean, Wei Jiandong, Labaze Georges, Hou Yunfang Joan, Babarsh Benjamin, Stutz Helen, et al. The role of complement system in septic shock. Clin Dev Immunol 2012, 2012:407324. 10.1155/2012/407324.
81. Ren Jianan, Zhao Yunzhao, Yuan Yujie, Han Gang, Li Weiqin, Huang Qian, et al. Complement depletion deteriorates clinical outcomes of severe abdominal sepsis: a conspirator of infection and coagulopathy in crime?. PLoS One 2012, 7(10):e47095. 10.1371/journal.pone.0047095.
82. Zhao Xin, Chen Yun-Xia, Li Chun-Sheng Predictive value of the complement system for sepsis-induced disseminated intravascular coagulation in septic patients in emergency department. J Crit Care 2015, 30(2):290-295. 10.1016/j.jcrc.2014.11.007.
83. Papayannopoulos Venizelos, Metzler Kathleen D., Hakkim Abdul, Zychlinsky Arturo Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 2010, 191(3):677-691. 10.1083/jcb.201006052.
84. Hashiba Masamitsu, Huq Aminul, Tomino Atsutoshi, Hirakawa Akihiko, Hattori Tomonori, Miyabe Hiromichi, et al. Neutrophil extracellular traps in patients with sepsis. J Surg Res 2015, 194(1):248-254. 10.1016/j.jss.2014.09.033.
85. Camicia Gabriela, Pozner Roberto, de Larrañaga Gabriela Neutrophil extracellular traps in sepsis. Shock 2014, 42(4):286-294. 10.1097/SHK.0000000000000221.
86. Gogos Charalambos, Kotsaki Antigone, Pelekanou Aimilia, Giannikopoulos George, Vaki Ilia, Maravitsa Panagiota, et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care 2010, 14(3):R96. 10.1186/cc9031.
87. Hotchkiss Richard S., Coopersmith Craig M., McDunn Jonathan E., Ferguson Thomas A. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009, 15(5):496-497. 10.1038/nm0509-496.
88. Monneret Guillaume, Venet Fabienne, Pachot Alexandre, Lepape Alain Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008, 14(1-2):64-78. 10.2119/2007-00102.Monneret.
89. Cajander Sara, Bäckman Anders, Tina Elisabet, Strålin Kristoffer, Söderquist Bo, Källman Jan Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis. Crit Care 2013, 17(5):R223. 10.1186/cc13046.
90. Payen Didier, Monneret Guillaume, Hotchkiss Richard Immunotherapy - a potential new way forward in the treatment of sepsis. Crit Care 2013, 17(1):118. 10.1186/cc12490.
91. Li Congcong, Bo Liyan, Liu Qingqing, Jin Faguang Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis. Int J Infect Dis 2015, 33:90-96. 10.1016/j.ijid.2014.12.032.
92. Venet Fabienne, Foray Anne-Perrine, Villars-Méchin Astrid, Malcus Christophe, Poitevin-Later Françoise, Lepape Alain, et al. IL-7 restores lymphocyte functions in septic patients. J Immunol 2012, 189(10):5073-5081. 10.4049/jimmunol.1202062.
93. Meisel Christian, Schefold Joerg C., Pschowski Rene, Baumann Tycho, Hetzger Katrin, Gregor Jan, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009, 180(7):640-648. 10.1164/rccm.200903-0363OC.
94. Bo Lulong, Wang Fei, Zhu Jiali, Li Jinbao, Deng Xiaoming Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Crit Care 2011, 15(1):R58. 10.1186/cc10031.
95. Döcke W.D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997, 3(6):678-681.
96. Leentjens Jenneke, Kox Matthijs, Koch Rebecca M., Preijers Frank, Joosten Leo AB., van der Hoeven Johannes G., et al. Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 2012, 186(9):838-845. 10.1164/rccm.201204-0645OC.
97. Shakoory Bita, Carcillo Joseph A., Chatham W Winn, Amdur Richard L., Zhao Huaqing, Dinarello Charles A., et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med 2015, 10.1097/CCM.0000000000001402.
98. Almansa Raquel, Tamayo Eduardo, Andaluz-Ojeda David, Nogales Leonor, Blanco Jesús, Eiros Jose Maria, et al. The original sins of clinical trials with intravenous immunoglobulins in sepsis. Crit Care 2015, 19:90. 10.1186/s13054-015-0793-0.
99. Djoumerska-Alexieva Iglika, Roumenina Lubka, Pashov Anastas, Dimitrov Jordan, Hadzhieva Maya, Lindig Sandro, et al. Intravenous immunoglobulin with enhanced polyspecificity improves survival in experimental sepsis and aseptic systemic inflammatory response syndromes. Mol Med 2015, 10.2119/molmed.2014.00224.
100. Luan Ying-yi, Yao Yong-ming, Xiao Xian-zhong, Sheng Zhi-yong Insights into the apoptotic death of immune cells in sepsis. J Interferon Cytokine Res 2015, 35(1):17-22. 10.1089/jir.2014.0069.
101. Chang Katherine, Svabek Catherine, Vazquez-Guillamet Cristina, Sato Bryan, Rasche David, Wilson Strother, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 2014, 18(1):R3. 10.1186/cc13176.
102. Almansa Raquel, Wain John, Tamayo Eduardo, Andaluz-Ojeda David, Martin-Loeches Ignacio, Ramirez Paula, et al. Immunological monitoring to prevent and treat sepsis. Crit Care 2013, 17(1):109. 10.1186/cc11922.